This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).
- Investigators
- Christopher Harden, Divya C Patel
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)
This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).
The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these鈥�
4 publications
2021
Chest
鈥�2021
Chest
鈥�2020
Chest
鈥�2017
Turkish journal of anaesthesiology and reanimation
鈥�